Despite studies that show that many adolescents and young adults with autism spectrum disorders are being prescribed medications, there is almost no evidence to show whether these medications are helpful in this population.
There is insufficient evidence to support findings, good or bad, for therapies currently used in adolescents and young adults with autism.
A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old.
Vanderbilt pediatric infectious disease researchers studying antibiotic-resistant staph say fears that mothers carrying the germ may set their newborns up for infection are unfounded.